Joshua W Kuethe1, Rachael Mintz-Cole, Bobby L Johnson, Emily F Midura, Charles C Caldwell, Barbara St Pierre Schneider. 1. Joshua W. Kuethe, MD, is General Surgery Resident; Rachael Mintz-Cole, PhD, is MD Candidate; Bobby L. Johnson III, MD, is General Surgery Resident; and Emily F. Midura, MD, is General Surgery Resident, College of Medicine, University of Cincinnati, Ohio. Charles C. Caldwell, PhD, is Associate Professor, College of Medicine, Department of Surgery, Division of Research, University of Cincinnati, Ohio. Barbara St. Pierre Schneider, DNSc, RN, is Associate Professor, School of Nursing, University of Nevada, Las Vegas.
Abstract
BACKGROUND: Unintentional injury or trauma remains the leading cause of death among young adults. About one fifth of these trauma patients require care in an intensive care unit (ICU) because of severity of injuries and comorbidities. Patients hospitalized in an ICU are at increased risk for nosocomial infections, such as urinary tract infections, pneumonia, bacteremia, and wound infections. Many of these patients will develop sepsis or septic shock, and some will progress to multiple organ failure and death. The balance between the proinflammatory and counterinflammatory immune response appears to be a driving factor in this progression. At present, there is no proposed method for the timely detection of the immune status in trauma patients, making rational decisions to use immune-altering therapies difficult. OBJECTIVE: We demonstrate that flow cytometry, with its capabilities to characterize and/or enumerate (a) leukocyte subtypes, (b) leukocyte activation markers, (c) leukocyte-derived cytokines and microvesicles, and (d) leukocyte function is well suited to monitor the immune status of critically ill trauma patients. METHODS: Information for the review was obtained from the extant literature. DISCUSSION: We suggest that flow cytometry is a research method that might aid nurse scientists in investigating the immune status of critically ill patients, the recovery status of conditions such as hemorrhagic shock and tissue injury and the relationship between cancer disease progression and symptoms. Therefore, flow cytometry has the potential to broaden nursing research priority areas so that a comprehensive approach to understanding the cellular response is attained.
BACKGROUND: Unintentional injury or trauma remains the leading cause of death among young adults. About one fifth of these traumapatients require care in an intensive care unit (ICU) because of severity of injuries and comorbidities. Patients hospitalized in an ICU are at increased risk for nosocomial infections, such as urinary tract infections, pneumonia, bacteremia, and wound infections. Many of these patients will develop sepsis or septic shock, and some will progress to multiple organ failure and death. The balance between the proinflammatory and counterinflammatory immune response appears to be a driving factor in this progression. At present, there is no proposed method for the timely detection of the immune status in traumapatients, making rational decisions to use immune-altering therapies difficult. OBJECTIVE: We demonstrate that flow cytometry, with its capabilities to characterize and/or enumerate (a) leukocyte subtypes, (b) leukocyte activation markers, (c) leukocyte-derived cytokines and microvesicles, and (d) leukocyte function is well suited to monitor the immune status of critically ill traumapatients. METHODS: Information for the review was obtained from the extant literature. DISCUSSION: We suggest that flow cytometry is a research method that might aid nurse scientists in investigating the immune status of critically illpatients, the recovery status of conditions such as hemorrhagic shock and tissue injury and the relationship between cancer disease progression and symptoms. Therefore, flow cytometry has the potential to broaden nursing research priority areas so that a comprehensive approach to understanding the cellular response is attained.
Authors: R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl Journal: J Immunol Date: 2001-06-01 Impact factor: 5.422
Authors: Mikael Roussel; Antoine Gros; Arnaud Gacouin; Nolwenn Le Meur; Yves Le Tulzo; Thierry Fest Journal: Cytometry B Clin Cytom Date: 2012-05-09 Impact factor: 3.058
Authors: David Andaluz-Ojeda; Verónica Iglesias; Felipe Bobillo; Mercedes Nocito; Ana M Loma; Concepción Nieto; Epifanio Ramos; Francisco Gandía; Lucía Rico; Jesús F Bermejo-Martin Journal: J Crit Care Date: 2013-08-15 Impact factor: 3.425
Authors: Reinaldo Salomao; Milena K C Brunialti; Natália E Gomes; Marialice E Mendes; Ricardo S Diaz; Shirley Komninakis; Flávia R Machado; Ismael D C Guerreiro da Silva; Otelo Rigato Journal: Crit Care Med Date: 2009-01 Impact factor: 7.598
Authors: Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall Journal: Nat Cell Biol Date: 2007-05-07 Impact factor: 28.824
Authors: David Andaluz-Ojeda; Verónica Iglesias; Felipe Bobillo; Raquel Almansa; Lucía Rico; Francisco Gandía; Ana Ma Loma; Concepción Nieto; Rosa Diego; Epifanio Ramos; Mercedes Nocito; Salvador Resino; Jose M Eiros; Eduardo Tamayo; Raul Ortiz de Lejarazu; Jesús F Bermejo-Martin Journal: Crit Care Date: 2011-10-21 Impact factor: 9.097
Authors: Teresa C Rice; Amanda M Pugh; Charles C Caldwell; Barbara St Pierre Schneider Journal: Crit Care Nurs Clin North Am Date: 2017-06-23 Impact factor: 1.326
Authors: Teresa C Rice; Amanda M Pugh; Aaron P Seitz; Erich Gulbins; Vanessa Nomellini; Charles C Caldwell Journal: J Surg Res Date: 2017-07-25 Impact factor: 2.192
Authors: Lillian Hesselink; Roy Spijkerman; Karlijn J P van Wessem; Leo Koenderman; Luke P H Leenen; Markus Huber-Lang; Falco Hietbrink Journal: World J Emerg Surg Date: 2019-05-29 Impact factor: 5.469